Nephrotic syndrome

Paediatrics and Child Health (United Kingdom)

Volumn 22, Issue 8, 2012, Pages 337-340

  Krishnan, Rajesh G ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Children; Nephrotic syndrome; Steroid dependence; Steroid resistance

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HUMAN ALBUMIN; LEVAMISOLE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; TACROLIMUS;

ALOPECIA; AZOOSPERMIA; BONE MARROW DEPRESSION; BONE MARROW SUPPRESSION; CLINICAL FEATURE; DISEASE CLASSIFICATION; DOSE RESPONSE; FIBROSIS; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENETICS; GONADAL DISEASE; GONADAL TOXICITY; HEMORRHAGIC CYSTITIS; HUMAN; HYPOVOLEMIA; INFECTION; LIVER TOXICITY; LUNG FIBROSIS; NEOPLASM; NEPHROTIC SYNDROME; OVARY FIBROSIS; PATHOPHYSIOLOGY; PATIENT CARE; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEINURIA; RASH; RELAPSE; REVIEW; TREATMENT RESPONSE;

EID: 84864296253     PISSN: 17517222     EISSN: 1878206X     Source Type: Journal    
DOI: 10.1016/j.paed.2012.02.004     Document Type: Review

References (14)

1. Bagga A., Sinha A., Moudgil A. Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 2007, 356:2751-2752.
2. Benoit G., Machuca E., Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 2010, 25:1621-1632.
3. Durkan A.M., Hodson E.M., Willis N.S., Craig J.C. Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials. Kidney Int 2001, 59:1919-1927.
4. Ekka B.K., Bagga A., Srivastava R.N. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome. Pediatr Nephrol 1997, 11:597-599.
5. Feehally J., Kendell N.P., Swift P.G., Walls J. High incidence of minimal change nephrotic syndrome in Asians. Arch Dis Child 1985, 60:1018-1020.
6. Gulati A., Sinha A., Jordan S.C., et al. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 2010, 5:2207-2212.
7. Hodson E.M., Craig J.C., Willis N.S. Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2005, 20:1523-1530.
8. Hodson E.M., Willis N.S., Craig J.C. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev 2008, Issue 1. Art. No.:CD002290.
9. Latta K., von Schnakenburg C., Ehrich J.H. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 2001, 16:271-282.
10. Mathieson P.W. Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant 2003, 18(suppl 6):vi26-vi29.
11. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 1978, 13:159-165.
12. Neuhaus T.J., Shah V., Callard R.E., Barratt T.M. T-lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood. Nephrol Dial Transplant 1995, 10:1348-1352.
13. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A report of the International Study of Kidney Disease in Children. Kidney Int 1981, 20:765-771.
14. van Husen M., Kemper M.J. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 2011, 26:881-892.